Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4

Lake Street analyst Ben Haynor has maintained a Buy rating on P3 Health Partners (NASDAQ: PIII) but has lowered the price target from $12.50 to $4. This adjustment reflects a significant decrease in the expected valuation of the company.